Swmg LLC Acquires 305 Shares of Zoetis Inc. $ZTS

Swmg LLC grew its holdings in Zoetis Inc. (NYSE:ZTS) by 19.3% in the 2nd quarter, HoldingsChannel reports. The firm owned 1,884 shares of the company’s stock after buying an additional 305 shares during the quarter. Swmg LLC’s holdings in Zoetis were worth $284,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Zoetis in the 2nd quarter valued at about $11,104,000. Novare Capital Management LLC raised its holdings in shares of Zoetis by 0.5% in the 2nd quarter. Novare Capital Management LLC now owns 96,171 shares of the company’s stock valued at $14,998,000 after purchasing an additional 501 shares in the last quarter. Quotient Wealth Partners LLC raised its holdings in shares of Zoetis by 38.6% in the 2nd quarter. Quotient Wealth Partners LLC now owns 4,391 shares of the company’s stock valued at $685,000 after purchasing an additional 1,224 shares in the last quarter. Stanley Laman Group Ltd. raised its holdings in shares of Zoetis by 11.3% in the 2nd quarter. Stanley Laman Group Ltd. now owns 1,977 shares of the company’s stock valued at $308,000 after purchasing an additional 200 shares in the last quarter. Finally, Nicholson Wealth Management Group LLC raised its holdings in shares of Zoetis by 7.7% in the 2nd quarter. Nicholson Wealth Management Group LLC now owns 8,933 shares of the company’s stock valued at $1,393,000 after purchasing an additional 640 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ZTS shares. Argus restated a “buy” rating and issued a $190.00 price target on shares of Zoetis in a report on Tuesday, September 9th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Piper Sandler boosted their price objective on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Finally, Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Zoetis has a consensus rating of “Hold” and a consensus target price of $196.71.

Zoetis Stock Up 0.6%

NYSE:ZTS opened at $144.15 on Friday. The company has a market cap of $63.88 billion, a PE ratio of 24.81, a P/E/G ratio of 2.32 and a beta of 0.90. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $193.49. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The company’s 50 day moving average is $148.73 and its two-hundred day moving average is $153.69.

Zoetis (NYSE:ZTS) last released its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis’s payout ratio is currently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.